Curran Financial Partners, LLC Johnson & Johnson Transaction History

Curran Financial Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $487,084 - $541,281	-3,016 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$159.48 - $171.07 $26,792 - $28,739	168 Added 5.9%	3,016 $497,000
Q1 2021 May 19, 2021	SELL	$153.07 - $170.48 $1,224 - $1,363	-8 Reduced 0.28%	2,848 $468,000
Q4 2020 Mar 01, 2021	BUY	$137.11 - $157.38 $391,586 - $449,477	2,856 New	2,856 $449,000

4,218

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $414B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Curran Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Curran Financial Partners, LLC with notifications on news.